Xiangyu Medical (688626.SH): Anyang Qixu Trade Consulting Service Center (Limited Partnership) reduced its holdings by 848,000 shares of the company.

Gelonghui, March 5th - Xiangyu Medical (688626.SH) announced that the company recently received a 'Notice Letter' issued by the information disclosure obligor, Anyang Qixu Trade Consulting Service Center (Limited Partnership). On March 5, 2026, the information disclosure obligor reduced its shares in the company by 848,000 through block trading, accounting for 0.53% of the company's total share capital. After this change in equity interest, the combined holdings of Anyang Qixu Trade Consulting Service Center (Limited Partnership), its acting-in-concert parties Henan Xiangyu Health Industry Management Co., Ltd., He Yongzheng, and Guo Junling decreased from 106 million shares to 105 million shares.

Gelonghui FinanceMar 5 19:26

Xiangyu Medical (688626.SH): Anyang Qixu Trade Consulting Service Center (Limited Partnership) has collectively reduced its holdings by 2,298,700 shares of the company.

Gelonghui, March 4th: Xiangyu Medical (688626.SH) announced that the company recently received a 'Notice Letter' issued by the information disclosure obligor, Anyang Qixu Trade Consulting Service Center (Limited Partnership). From February 11, 2026, to March 4, 2026, the information disclosure obligor reduced its shares in the company by 696,900 shares through centralized bidding and by 1,601,800 shares through block trading, totaling a reduction of 2,298,700 shares, representing 1.44% of the company's total share capital.

Gelonghui FinanceMar 4 19:33

Xiangyu Medical’s 2025 Annual Performance Quick Report Announcement

SZSIFeb 28 00:00 · Announcements

Express News | Xiangyu Medical: Net profit of 78.7 million yuan in 2025, a year-on-year decrease of 23.55%.

BreakingsFeb 27 16:26

Express News | The concept of brain-computer interface became active in the afternoon, with Botuo Bio rising over 10%.

BreakingsFeb 13 14:13

Zhejiang Securities: Brain-computer interface reaches broader markets amid domestic policy and industrial window period convergence.

In the future, assuming communication bandwidth becomes the bottleneck between biology and technology, ordinary people will interact with AI and control complex machinery through brain-computer interfaces.

Zhitong FinanceFeb 10 15:15